Introduction of new drug supply model in the tb service practice
Aim. To create and introduce in practice of the TB service of the Chelyabinsk region a new model of drug supply with personalized centralized distribution of anti-TB second line drugs. Materials and methods. Since 2012 the anti-tuberculosis service of the Chelyabinsk region introduced the model of drug supply «medicine is a patient - medical organization». For personalized taking into account the Register of pharmacotherapy of patients with MDR tuberculosis. Division of clinical pharmacology performed the task to coordinate all the doctors of the TB on the issues of chemotherapy of drug-resistant tuberculosis and its complications. The introduction of the new distribution model for the first time allowed patients to receive treatment as close as possible to the place of residence, and thereby increased adherence to treatment of tuberculosis. Results. The advantages of this model is that the rotation of the patient (detection, diagnosis of MDR TB, chemotherapy on the stationary stage, surgical stage, chemotherapy in stationary phase, outpatient treatment), the required amount of drugs is allocated only to a specific institution. This has led to a more rational use of budget funds within the TB service of the Chelyabinsk region. Conclusion. The introduction of a new model of drug provision for patients with MDR tuberculosis in the Chelyabinsk region have increased the availability of treatment for patients at all stages, including as close to the place of permanent residence.